CVS beats, says Aetna deal will close before Thanksgiving (CVS)

pulse

November 6, 2018 2:56 PM

CVS posted third-quarter earnings that beat on both the profits and sales, sending shares up as much as 3% before Tuesday's opening bell.

The company said its proposed acquisition of Aetna will close before Thanksgiving.

CVS posted third-quarter earnings that beat on both profits and sales, sending shares up as much as 3% before Tuesday's opening bell. The company also reiterated its full-year guidance.

Here are the key numbers, comparing to estimates from analysts surveyed by Bloomberg:

Earnings per share:
$1.73
Revenue:
$47.3 billion
Same-store sales growth:
Same-store prescription volume growth:
+9.2%
Full-year EPS guidance:
$6.89 to $7.08

Aetna has found a buyer for the business — a subsidiary of WellCare Health Plans — and so the transaction is expected to close prior to Thanksgiving, CVS said in Tuesday's press release.

CVS was up 3% this year through Monday.

Read more stories on CVS:

CVS and Aetna are gaining ground after their $69 billion merger gets the green light
VS is fending off Amazon in drug delivery

pulse

Enhance Your Pulse News Experience!

Get rewards worth up to $20 when selected to participate in our exclusive focus group. Your input will help us to make informed decisions that align with your needs and preferences.

I've got feedback!

JOIN OUR PULSE COMMUNITY!

Unblock notifications in browser settings.

Eyewitness? Submit your stories now via social or:

Email: eyewitness@pulse.ng